In several studies, PTEN mutation was associated with improved overall survival [38,88], whereas other reports demonstrated negative impacts of mutated PTEN on clinical outcomes in IDH—wildtype glioblastoma patients [94,95]. Here, IDH2 is linked to glioblastoma.